Cargando…
Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide
BACKGROUND: HIV is primarily transmitted by sexual intercourse and predominantly infects people in Third World countries. Here an important medical need is self-protection for women, particularly in societies where condoms are not widely accepted. Therefore, availability of antiviral microbicides ma...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957839/ https://www.ncbi.nlm.nih.gov/pubmed/27450669 http://dx.doi.org/10.1186/s12879-016-1713-x |
_version_ | 1782444234547134464 |
---|---|
author | Voges, Maike Schneider, Carola Sinn, Malte Hartig, Jörg S. Reimer, Rudolph Hauber, Joachim Moelling, Karin |
author_facet | Voges, Maike Schneider, Carola Sinn, Malte Hartig, Jörg S. Reimer, Rudolph Hauber, Joachim Moelling, Karin |
author_sort | Voges, Maike |
collection | PubMed |
description | BACKGROUND: HIV is primarily transmitted by sexual intercourse and predominantly infects people in Third World countries. Here an important medical need is self-protection for women, particularly in societies where condoms are not widely accepted. Therefore, availability of antiviral microbicides may significantly reduce sexual HIV transmission in such environments. METHODS: Here, we investigated structural characteristics and the antiviral activity of the polypurine tract (PPT)-specific ODN A, a 54-mer oligodeoxynucleotide (ODN) that has been previously shown to trigger the destruction of viral RNA genomes by prematurely activating the retroviral RNase H. The stability of ODN A and mutants thereof was tested at various storage conditions. Furthermore, antiviral effects of ODN A were analyzed in various tissue culture HIV-1 infection models. Finally, circular dichroism spectroscopy was employed to gain insight into the structure of ODN A. RESULTS: We show here that ODN A is a powerful tool to abolish HIV-1 particle infectivity, as required for a candidate compound in vaginal microbicide applications. We demonstrate that ODN A is not only capable to prematurely activate the retroviral RNase H, but also prevents HIV-1 from entering host cells. ODN A also exhibited extraordinary stability lasting several weeks. Notably, ODN A is biologically active under various storage conditions, as well as in the presence of carboxymethylcellulose CMC (K-Y Jelly), a potential carrier for application as a vaginal microbicide. ODN A’s remarkable thermostability is apparently due to its specific, guanosine-rich sequence. Interestingly, these residues can form G-quadruplexes and may lead to G-based DNA hyperstructures. Importantly, the pronounced antiviral activity of ODN A is maintained in the presence of human semen or semen-derived enhancer of virus infection (SEVI; i.e. amyloid fibrils), both known to enhance HIV infectivity and reduce the efficacy of some antiviral microbicides. CONCLUSIONS: Since ODN A efficiently inactivates HIV-1 and also displays high stability and resistance against semen, it combines unique and promising features for its further development as a vaginal microbicide against HIV. |
format | Online Article Text |
id | pubmed-4957839 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49578392016-07-26 Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide Voges, Maike Schneider, Carola Sinn, Malte Hartig, Jörg S. Reimer, Rudolph Hauber, Joachim Moelling, Karin BMC Infect Dis Research Article BACKGROUND: HIV is primarily transmitted by sexual intercourse and predominantly infects people in Third World countries. Here an important medical need is self-protection for women, particularly in societies where condoms are not widely accepted. Therefore, availability of antiviral microbicides may significantly reduce sexual HIV transmission in such environments. METHODS: Here, we investigated structural characteristics and the antiviral activity of the polypurine tract (PPT)-specific ODN A, a 54-mer oligodeoxynucleotide (ODN) that has been previously shown to trigger the destruction of viral RNA genomes by prematurely activating the retroviral RNase H. The stability of ODN A and mutants thereof was tested at various storage conditions. Furthermore, antiviral effects of ODN A were analyzed in various tissue culture HIV-1 infection models. Finally, circular dichroism spectroscopy was employed to gain insight into the structure of ODN A. RESULTS: We show here that ODN A is a powerful tool to abolish HIV-1 particle infectivity, as required for a candidate compound in vaginal microbicide applications. We demonstrate that ODN A is not only capable to prematurely activate the retroviral RNase H, but also prevents HIV-1 from entering host cells. ODN A also exhibited extraordinary stability lasting several weeks. Notably, ODN A is biologically active under various storage conditions, as well as in the presence of carboxymethylcellulose CMC (K-Y Jelly), a potential carrier for application as a vaginal microbicide. ODN A’s remarkable thermostability is apparently due to its specific, guanosine-rich sequence. Interestingly, these residues can form G-quadruplexes and may lead to G-based DNA hyperstructures. Importantly, the pronounced antiviral activity of ODN A is maintained in the presence of human semen or semen-derived enhancer of virus infection (SEVI; i.e. amyloid fibrils), both known to enhance HIV infectivity and reduce the efficacy of some antiviral microbicides. CONCLUSIONS: Since ODN A efficiently inactivates HIV-1 and also displays high stability and resistance against semen, it combines unique and promising features for its further development as a vaginal microbicide against HIV. BioMed Central 2016-07-22 /pmc/articles/PMC4957839/ /pubmed/27450669 http://dx.doi.org/10.1186/s12879-016-1713-x Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Voges, Maike Schneider, Carola Sinn, Malte Hartig, Jörg S. Reimer, Rudolph Hauber, Joachim Moelling, Karin Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide |
title | Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide |
title_full | Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide |
title_fullStr | Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide |
title_full_unstemmed | Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide |
title_short | Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide |
title_sort | abolishing hiv-1 infectivity using a polypurine tract-specific g-quadruplex-forming oligonucleotide |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957839/ https://www.ncbi.nlm.nih.gov/pubmed/27450669 http://dx.doi.org/10.1186/s12879-016-1713-x |
work_keys_str_mv | AT vogesmaike abolishinghiv1infectivityusingapolypurinetractspecificgquadruplexformingoligonucleotide AT schneidercarola abolishinghiv1infectivityusingapolypurinetractspecificgquadruplexformingoligonucleotide AT sinnmalte abolishinghiv1infectivityusingapolypurinetractspecificgquadruplexformingoligonucleotide AT hartigjorgs abolishinghiv1infectivityusingapolypurinetractspecificgquadruplexformingoligonucleotide AT reimerrudolph abolishinghiv1infectivityusingapolypurinetractspecificgquadruplexformingoligonucleotide AT hauberjoachim abolishinghiv1infectivityusingapolypurinetractspecificgquadruplexformingoligonucleotide AT moellingkarin abolishinghiv1infectivityusingapolypurinetractspecificgquadruplexformingoligonucleotide |